Hypogonadism Resource Center News

 
 
  • SMSNA Long-term Testosterone Beneficial in Hypogonadal Men For hypogonadal men, testosterone improves urinary and erectile function, body composition, and glycemic control, researchers report, and is undeserving of its bad reputation.
  • Post-Finasteride Syndrome Not Related to Androgen Deficiency Men who report persistent sexual symptoms after using finasteride for hair loss do not show abnormalities in androgens or their receptors, according to a new report.
  • Pituitary Hormones Should Be 'Restored to Healthy Levels' Hormone levels in hypopituitarism patients should be restored to healthy levels, taking into account interaction between hormones and other medications, say newly issued guidelines.
  • Data: May Be OK to Give 'T' to Men With Prostate Cancer The idea of prescribing testosterone to men with prostate cancer was once an anathema. But new data from a small patient cohort suggest that it may be okay.
  • ECNP Light Therapy May Boost Low Libido in Men Light therapy similar to that used to treat seasonal affective disorder may increase sexual desire in men with a low libido via an increase in testosterone levels, an Italian study suggests.
  • More Than 1 in 4 Adults Get No Regular Exercise, Study Shows Inactivity was most prevalent among those with chronic illness or those with less than a high school degree, according to a study of Americans aged 50 years or older.
  • 2% Testosterone Ups Sex Drive, Energy for Men With Low T A once-daily 2% testosterone solution, applied under the arm, increased energy and sex drive in a 6-month open-label extension of a 3-month double-blind study, without adding adverse effects.
  • Do Cell Phones Cause Cancer? Maybe Yes and No It could be that cell phones do not directly cause cancer but instead act as a trigger after exposure to other types of carcinogens.
  • Insufficient Evidence to Choose Best Management of Renal Artery Stenosis There is insufficient evidence to choose between percutaneous transluminal renal angioplasty with stent placement (PTRAS) and medical therapy alone for adults with atherosclerotic renal artery stenosis (ARAS), according to findings of an updated systematic review.
  • A Survival 'Paradox' in Colon Cancer Patients with stage IIB/C colon cancers have worse survival than those with the higher stage IIIA disease. A study looks at factors that might explain the paradox.
  • Testosterone Boosts Sexual Function in Men, Across the Board Older men with low testosterone and low libido treated with testosterone experience improvements in sexual desire and activity across the vast majority of domains, US study findings suggest.
  • Testosterone No Elixir for the Brain in Healthy Aging Men Prescribing testosterone to healthy older men does not improve cognitive function, new research shows.
  • Depression May Be a Dementia Prodrome A gradual increase in depressive symptoms, as opposed to more stable symptoms, is linked to an increased risk of developing dementia, new research shows.
  • Top 10 Causes of Death in the US Heart disease and cancer were the top two causes of death in the United States in 2014; the death rate hits an all-time low.
  • Weight Loss Does Not Improve Infertility Treatment Outcomes Obese, infertile women who participated in a weight loss program before infertility treatment were no more likely to conceive and deliver a healthy infant than those who had prompt treatment.
  • AUA Long-term Testosterone May Decrease Cardiovascular Risk Long-term testosterone therapy is safe, according to a large population-based cohort study, but not all experts agree that the controversy surrounding the treatment is resolved.
  • ACOG Zika Will Headline Obstetricians and Gynecologists Meeting Clinicians attending the American Congress of Obstetricians and Gynecologists will learn about the management of Zika, the role of flibanserin in sexual desire, and the future of the Pap test.
  • Testosterone Pill Is Safe, Has 'Very Good Science' A new oral testosterone formulation for hypogonadism has no liver toxicity, which has been a problem with other testosterone pills.
  • Review Calls for More Research on Transgender Hormone Therapy A new review details the benefits, risks, and effects of testosterone therapy in transgender men, highlighting the lack of long-term data and calling for more research that can help guide patient care.
  • Tumor Marker Role in Metastatic Prostate Cancer A tumor marker in peripheral blood may help determine which men with metastatic castration-resistant prostate cancer (mCRPC) respond well to docetaxel and which will benefit from a different therapy, researchers from Spain suggests.